Roche Q1 sales solid as Illumina bid battle rages

ZURICH (Reuters) - Swiss drugmaker Roche said it would have to rethink its tactics if shareholders of reluctant U.S. bid target Illumina did not back its approach as it reported strong first-quarter pharmaceutical sales helped by top cancer drugs.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Ilq8ZsZsk00/us-roche-idUSBRE83B09A20120412

phlebotomy certification in tennessee phlebotomy classes in chicago phlebotomist schools